(1.28%) 5 129.04 points
(1.26%) 38 706 points
(1.99%) 16 155 points
(-0.80%) $78.32
(5.31%) $2.14
(0.00%) $2 309.70
(-0.38%) $26.73
(0.42%) $966.60
(-0.35%) $0.929
(-1.22%) $10.86
(-0.10%) $0.797
(0.37%) $91.47
4.21% $ 10.42
@ $2.19
Wydano: 14 vas. 2024 @ 16:34
Zwrot: 375.80%
Poprzedni sygnał: vas. 12 - 23:00
Poprzedni sygnał:
Zwrot: 10.05 %
Live Chart Being Loaded With Signals
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema...
Stats | |
---|---|
Dzisiejszy wolumen | 802 427 |
Średni wolumen | 330 547 |
Kapitalizacja rynkowa | 216.27M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $-1.280 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.900 |
ATR14 | $0.0280 (0.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-03 | Seyedkazemi Setareh | Buy | 85 000 | Stock Option (Right to Buy) |
2023-10-03 | Soparkar Peter | Buy | 130 000 | Stock Option (Right to Buy) |
2023-10-03 | Fischer Laurent | Buy | 315 000 | Stock Option (Right to Buy) |
2024-02-12 | Seyedkazemi Setareh | Buy | 400 000 | Stock Option (Right to Buy) |
2024-02-12 | Fischer Laurent | Buy | 1 104 200 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
97.18 |
Last 100 transactions |
Buy: 14 665 896 | Sell: 1 551 540 |
Wolumen Korelacja
Adverum Biotechnologies Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RVNC | 0.965 |
VCNX | 0.964 |
LYT | 0.963 |
SBET | 0.959 |
RSLS | 0.957 |
HA | 0.957 |
BCLI | 0.956 |
FDMT | 0.955 |
STKS | 0.954 |
TNYA | 0.953 |
10 Najbardziej negatywne korelacje | |
---|---|
RMRM | -0.971 |
ACQR | -0.963 |
TBSA | -0.962 |
HERA | -0.962 |
NVSA | -0.961 |
FRSG | -0.961 |
LEGA | -0.96 |
FTPA | -0.96 |
GXII | -0.96 |
AGGR | -0.96 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Adverum Biotechnologies Korelacja - Waluta/Towar
Adverum Biotechnologies Finanse
Annual | 2023 |
Przychody: | $3.60M |
Zysk brutto: | $-2.04M (-56.78 %) |
EPS: | $-11.62 |
FY | 2023 |
Przychody: | $3.60M |
Zysk brutto: | $-2.04M (-56.78 %) |
EPS: | $-11.62 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-6.53M (0.00 %) |
EPS: | $-15.57 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.709 |
Financial Reports:
No articles found.
Adverum Biotechnologies
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej